Guilin Sanjin Pharmaceutical Co., Ltd. (SHE:002275)

China flag China · Delayed Price · Currency is CNY
13.22
+0.09 (0.69%)
Jul 29, 2026, 3:04 PM CST
Market Cap7.77B -11.7%
Revenue (ttm)2.10B -3.4%
Net Income452.67M -14.0%
EPS0.77 -14.5%
Shares Out 587.57M
PE Ratio17.17
Forward PEn/a
Dividend0.50 (3.81%)
Ex-Dividend DateJun 4, 2026
Volume1,992,000
Open13.17
Previous Close13.13
Day's Range13.11 - 13.33
52-Week Range11.91 - 17.38
Beta0.21
Analystsn/a
Price Targetn/a
Earnings DateAug 22, 2026

About SHE:002275

Guilin Sanjin Pharmaceutical Co., Ltd. engages in the research, production, manufacturing, and sale of traditional Chinese medicines in China and internationally. The company offers Sanjin Tablets, Sanjinpian, Guilin Watermelon Frost, Watermelon Frost Throat Lozenges, Guilin Watermelon Frost Lozenges, Watermelon Frost Throat Clearing Lozenges, Vertigo Relief Tablets/Granules, Gecko Asthma Relief Capsules, Lamotrigine Tablets (Anxian), Naomaitai Capsules, Yuye Detoxification Granules, and Compound Tianqi Stomach Pain Capsules, Soothing Throat Sp... [Read more]

Sector Healthcare
Founded 1985
Employees 2,556
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002275
Full Company Profile

Financial Performance

In 2025, SHE:002275's revenue was 2.05 billion, a decrease of -6.76% compared to the previous year's 2.19 billion. Earnings were 433.13 million, a decrease of -16.95%.

Financial Statements